MML Growth Capital Partners to invest in Cruinn Diagnostics for €12m.

MML Growth Capital Partners, a mid-market private equity firm, agreed to invest in Cruinn Diagnostics, a laboratory equipment supplier, for €12m. "We are delighted to receive this investment from MML. This investment will give Cruinn the additional financial support to expand in its target markets," Jack Nolan, Cruinn Managing Director.